Quick links
Korean J. Vet. Serv. 2024; 47(2): 89-94
Published online June 30, 2024
https://doi.org/10.7853/kjvs.2024.47.2.89
© The Korean Socitety of Veterinary Service
Correspondence to : Woo-Jin Song
E-mail: ssong@jejunu.ac.kr
https://orcid.org/0000-0002-9195-551X
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0). which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
A 5-year-old spayed female mixed-breed dog, previously receiving 7 months of immunosuppressive therapy for pemphigus foliaceus, presented to our referral hospital with a history of dog bites on the right forelimb, chest, and flank 4 days prior to presentation. Physical examination revealed a rectal temperature of 38.6℃; heart rate of 130 beats per minute; panting; systolic blood pressure of 60 mmHg; and swelling, purulent discharge, warmth, pain, and lameness in the right forelimb. The laboratory investigation revealed neutropenia and elevated C-reactive protein levels. Suppurative neutrophilic infiltration with bacterial infection was detected by impression cytology of the pus on the right forelimb. Based on the results of the clinical examinations and laboratory tests, the dog was diagnosed with dog bite-induced sepsis with pemphigus. Meropenem and metronidazole were prescribed. Clinical signs, neutropenia, and C-reactive protein levels markedly improved after 5 days. Subsequently, pemphigus foliaceus relapsed in the dog, and it is currently undergoing re-administration of immunosuppressive medications. To the best of our knowledge, this is the first case report of successful management of dog bite-induced sepsis in a dog undergoing long-term immunosuppressive therapy.
Keywords Bite, Dog, Immunosuppressive therapy, Pemphigus, Sepsis
The onset of sepsis triggers both pro-inflammatory and anti-inflammatory processes, and the balance between these processes is crucial for survival (Hotchkiss and Karl, 2003). An imbalance where pro-inflammatory responses dominate can lead to a cytokine storm and subsequent fatality, while an excessive anti-inflammatory response can result in nosocomial infections or reactivation of pathogens, leading to death.
A 5-year-old spayed female mixed-breed dog (weight, 29.8 kg), previously on 7 months of immunosuppressive therapy (prednisolone 0.5 mg/kg, per oral [PO], q12h [Solondo Tab., Yuhan, Seoul, Korea] and cyclosporine 8 mg/kg, PO, q24h [Cipol-N Soft Cap. 100 mg, Chong Kun Dang, Seoul, Korea]) for pemphigus foliaceus (Fig. 1), presented to our referral hospital with a history of dog bites on the right forelimb, chest, and flank 4 days prior (Fig. 2A). Physical examination revealed a rectal temperature of 38.6℃; heart rate of 130 beats per minute; panting; systolic blood pressure of 60 mmHg (Doppler method); and swelling, purulent discharge, warmth, pain, and lameness in the right forelimb (Fig. 2B). Laboratory investigations, including complete blood count (CBC) and serum chemistry, were performed using blood samples from the jugular vein. Neutropenia (neutrophil, 2,360 /μL; reference interval [RI] 2,950∼11,640 /μL) was found in the CBC. Elevation of C-reactive protein (CRP, 7.8 mg/dL; RI 0.1∼1 mg/dL), γ-glutamyl transferase (GGT, 223 U/L; RI 0∼11 U/L), and alkaline phosphatase (ALP, 2,970 U/L; RI 23∼212 U/L) were found in the serum chemistry (Table 1). There were no remarkable findings on radiography, and ultrasound examination of the right forelimb revealed a hypoechoic lesion suspected to be a purulent exudate located between the muscles (Fig. 2C). Suppurative neutrophilic infiltration with bacterial infection was detected by impression cytology of the pus on the right forelimb (Fig. 3). Pasteurella canis was isolated from pus cultures. Based on the results of these clinical examinations and laboratory findings, the dog was diagnosed with dog bite-induced sepsis with pemphigus.
Table 1 . Complete blood count (CBC) and serum chemistry results at initial visit
CBC | ||
---|---|---|
RBC | 8.86 | 5.65∼8.87 (1012/L) |
HCT | 46 | 37.3∼61.7 (%) |
WBC | 5.87 | 5.05∼16.76 (109/L) |
WBC-NEU † | 2.36 | 2.95∼11.64 (103/µL) |
WBC-LYM † | 1.49 | 1.05∼5.1 (103/µL) |
WBC-MONO† | 2 | 0.16∼1.12 (103/µL) |
WBC-EOS† | 0.02 | 0.06∼1.23 (103/µL) |
WBC-BASO† | 0 | 0∼0.1 (103/µL) |
Platelet | 229 | 148∼484 (109/L) |
Serum chemistry | ||
Glucose | 127 | 74∼143 (mg/dL) |
PHOS | 5.8 | 2.5∼6.8 (mg/dL) |
Calcium | 9.1 | 7.9∼12 (mg/dL) |
TP | 7.3 | 5.2∼ 8.2 (g/dL) |
ALB | 3.1 | 2.3∼ 4 (g/dL) |
GLB | 4.2 | 2.5∼4.5 (g/dL) |
ALT | 167 | 10∼125 (U/L) |
AST | 59 | 0∼50 (U/L) |
ALKP | 2,970 | 23∼212 (U/L) |
GGT | 223 | 0∼11 (U/L) |
Bilirubin-Total | 0.6 | 0∼0.9 (mg/dL) |
CHOL | 261 | 110∼320 (mg/dL) |
Creatinine | 0.6 | 0.5∼1.8 (mg/dL) |
BUN | 6 | 7∼27 (mg/dL) |
CRP | 7.8 | 0.1∼1 (mg/dL) |
ALB, albumin; ALKP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; BASO, basophil; BUN, blood urea nitrogen; CHOL, cholesterol; CRP, C-reactive protein; GGT, γ-glutamyl transferase; GLB, globulin; HCT, haematocrit; LYM, lymphocyte; MONO, monocyte; NEU, neutrophil; PHOS, phosphate; RBC, red blood cell; TP, total protein; WBC, white blood cell.
During hospitalization, immunosuppressants were discontinued, and a combination of two broad-spectrum antibacterial drugs (cefotaxime 30 mg/kg, intravenous [IV], q8h [Pharmgen cefotaxime sodium inj. 1 g, Pharmgen Science, Seoul, Korea] and enrofloxacin 10 mg/kg, IV, q24h [Baytril 50 inj., Yuhan]) was administered. Additionally, the dog received fluid (Plasma Solution-A Inj., HK inno.N Corp., Cheongju, Korea; bolus or continuous rate infusion [CRI]) for hypotension, analgesic treatment (remifentanil 6 μg/kg/hr, lidocaine 3 mg/kg/hr, and ketamine 0.6 mg/kg/hr, CRI), and gastrointestinal medications (esomeprazole 1 mg/kg, IV, q24h [Nexium inj., AstraZeneca, Cambridge, UK] and metoclopramide hydrochloride 0.3 mg/kg, subcutaneous, q12h [Meckool inj., Jeil jeyak, Daegu, Korea]). However, CRP and neutropenia did not stabilize after treatment with these broad-spectrum antibacterial drugs for 2 days (Fig. 4). Therefore, we decided to change the antibacterial drugs, and on day 2, the dog received meropenem (12 mg/kg, IV, q8h [Meropen inj. 0.5 g, Yuhan]) and metronidazole (7.5 mg/kg, IV, q 12h [Trizele inj., JW Pharmaceutical, Gyeonggi, Korea]) for antibacterial treatment. Subsequently, the CRP levels, neutropenia, and injuries markedly improved (Fig. 4). The dog was discharged from the hospital on day 5. On the day of discharge, meropenem and metronidazole for antibacterial treatment, and oxycodone (0.3 mg/kg, PO, q 12h [Ocodone Tab. 5 mg, Hana Pharm, Seoul, Korea]) for analgesia were prescribed . The dog was rechecked on day 21. The CRP level was within the normal reference range, and the clinical signs were completely resolved. However, pemphigus foliaceus relapsed in the dog, and the dog is currently undergoing re-administration of immunosuppressive medications (prednisolone 1 mg/kg, PO, SID and cyclosporine 8 mg/kg, PO, SID).
Millions of animal injuries occur annually (Lauer et al, 1982; Weiss et al, 1998). Among these, 90% involve injuries caused by dogs and cats, and 3∼18% of dog bites result in infections (Talan et al, 1999). Aerobic bacteria commonly isolated from dog bites include
Several studies on the autopsies of patients who died from sepsis revealed significantly suppressed cytokine production in splenocytes (Meakins et al, 1977; Hotchkiss and Karl, 2003). Given this immunosuppressive state in patients with sepsis, there is a current argument to focus not only on appropriate antibiotic therapy and supportive care, but also on enhancing the host’s immunity (Meisel et al, 2009; Hall et al, 2011). Therefore, immunosuppressive therapy the dog was receiving for pemphigus was discontinued.
When there is a recurrence or persistent hypotension due to septic shock, the delay in initiating effective antibiotic treatment significantly increases the risk of death (Kumar et al, 2006a; Kumar et al, 2006b). According to a study by Kumar et al., if effective antibiotic therapy begins within one hour of confirming hypotension, the survival rate markedly improves (Kumar et al, 2006a). However, for each subsequent delay, the average survival rate decreases by 7.6% (Kumar et al, 2006a). This emphasizes the critical importance of early and effective antibiotic interventions (Garnacho-Montero et al, 2003; Larché et al, 2003). Based on this evidence, in this patient, the combination of cefotaxime and enrofloxacin did not improve persistent hypotension and worsening neutropenia. Therefore, treatment was changed to a combination of meropenem and metronidazole (Roberts et al, 2009). Subsequently, the CRP levels, neutropenia, and injury significantly improved.
To the best of our knowledge, this is the first case report of successful management of dog bite-induced sepsis in a dog undergoing long-term immunosuppressive therapy.
This study was supported by the National Research Foundation (NRF) of Korea grant funded by the Korea government (MSIT) (RS-2023-00252033).
The dog described in this report was a client-owned patient presented for care at the veterinary medical teaching hospital of Jeju National University. Informed owner consent was received for any possible research use of all diagnostic samples acquired from the dog.
No potential conflict of interest relevant to this article was reported.
Korean J. Vet. Serv. 2024; 47(2): 89-94
Published online June 30, 2024 https://doi.org/10.7853/kjvs.2024.47.2.89
Copyright © The Korean Socitety of Veterinary Service.
Sooyoung Son 1, Woo-Jin Song 1,2*
1Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Jeju National University, Jeju 63243, Korea
2Research Institute of Veterinary Science, College of Veterinary Medicine, Jeju National University, Jeju 63243, Korea
Correspondence to:Woo-Jin Song
E-mail: ssong@jejunu.ac.kr
https://orcid.org/0000-0002-9195-551X
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0). which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
A 5-year-old spayed female mixed-breed dog, previously receiving 7 months of immunosuppressive therapy for pemphigus foliaceus, presented to our referral hospital with a history of dog bites on the right forelimb, chest, and flank 4 days prior to presentation. Physical examination revealed a rectal temperature of 38.6℃; heart rate of 130 beats per minute; panting; systolic blood pressure of 60 mmHg; and swelling, purulent discharge, warmth, pain, and lameness in the right forelimb. The laboratory investigation revealed neutropenia and elevated C-reactive protein levels. Suppurative neutrophilic infiltration with bacterial infection was detected by impression cytology of the pus on the right forelimb. Based on the results of the clinical examinations and laboratory tests, the dog was diagnosed with dog bite-induced sepsis with pemphigus. Meropenem and metronidazole were prescribed. Clinical signs, neutropenia, and C-reactive protein levels markedly improved after 5 days. Subsequently, pemphigus foliaceus relapsed in the dog, and it is currently undergoing re-administration of immunosuppressive medications. To the best of our knowledge, this is the first case report of successful management of dog bite-induced sepsis in a dog undergoing long-term immunosuppressive therapy.
Keywords: Bite, Dog, Immunosuppressive therapy, Pemphigus, Sepsis
The onset of sepsis triggers both pro-inflammatory and anti-inflammatory processes, and the balance between these processes is crucial for survival (Hotchkiss and Karl, 2003). An imbalance where pro-inflammatory responses dominate can lead to a cytokine storm and subsequent fatality, while an excessive anti-inflammatory response can result in nosocomial infections or reactivation of pathogens, leading to death.
A 5-year-old spayed female mixed-breed dog (weight, 29.8 kg), previously on 7 months of immunosuppressive therapy (prednisolone 0.5 mg/kg, per oral [PO], q12h [Solondo Tab., Yuhan, Seoul, Korea] and cyclosporine 8 mg/kg, PO, q24h [Cipol-N Soft Cap. 100 mg, Chong Kun Dang, Seoul, Korea]) for pemphigus foliaceus (Fig. 1), presented to our referral hospital with a history of dog bites on the right forelimb, chest, and flank 4 days prior (Fig. 2A). Physical examination revealed a rectal temperature of 38.6℃; heart rate of 130 beats per minute; panting; systolic blood pressure of 60 mmHg (Doppler method); and swelling, purulent discharge, warmth, pain, and lameness in the right forelimb (Fig. 2B). Laboratory investigations, including complete blood count (CBC) and serum chemistry, were performed using blood samples from the jugular vein. Neutropenia (neutrophil, 2,360 /μL; reference interval [RI] 2,950∼11,640 /μL) was found in the CBC. Elevation of C-reactive protein (CRP, 7.8 mg/dL; RI 0.1∼1 mg/dL), γ-glutamyl transferase (GGT, 223 U/L; RI 0∼11 U/L), and alkaline phosphatase (ALP, 2,970 U/L; RI 23∼212 U/L) were found in the serum chemistry (Table 1). There were no remarkable findings on radiography, and ultrasound examination of the right forelimb revealed a hypoechoic lesion suspected to be a purulent exudate located between the muscles (Fig. 2C). Suppurative neutrophilic infiltration with bacterial infection was detected by impression cytology of the pus on the right forelimb (Fig. 3). Pasteurella canis was isolated from pus cultures. Based on the results of these clinical examinations and laboratory findings, the dog was diagnosed with dog bite-induced sepsis with pemphigus.
Table 1 . Complete blood count (CBC) and serum chemistry results at initial visit.
CBC | ||
---|---|---|
RBC | 8.86 | 5.65∼8.87 (1012/L) |
HCT | 46 | 37.3∼61.7 (%) |
WBC | 5.87 | 5.05∼16.76 (109/L) |
WBC-NEU † | 2.36 | 2.95∼11.64 (103/µL) |
WBC-LYM † | 1.49 | 1.05∼5.1 (103/µL) |
WBC-MONO† | 2 | 0.16∼1.12 (103/µL) |
WBC-EOS† | 0.02 | 0.06∼1.23 (103/µL) |
WBC-BASO† | 0 | 0∼0.1 (103/µL) |
Platelet | 229 | 148∼484 (109/L) |
Serum chemistry | ||
Glucose | 127 | 74∼143 (mg/dL) |
PHOS | 5.8 | 2.5∼6.8 (mg/dL) |
Calcium | 9.1 | 7.9∼12 (mg/dL) |
TP | 7.3 | 5.2∼ 8.2 (g/dL) |
ALB | 3.1 | 2.3∼ 4 (g/dL) |
GLB | 4.2 | 2.5∼4.5 (g/dL) |
ALT | 167 | 10∼125 (U/L) |
AST | 59 | 0∼50 (U/L) |
ALKP | 2,970 | 23∼212 (U/L) |
GGT | 223 | 0∼11 (U/L) |
Bilirubin-Total | 0.6 | 0∼0.9 (mg/dL) |
CHOL | 261 | 110∼320 (mg/dL) |
Creatinine | 0.6 | 0.5∼1.8 (mg/dL) |
BUN | 6 | 7∼27 (mg/dL) |
CRP | 7.8 | 0.1∼1 (mg/dL) |
ALB, albumin; ALKP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; BASO, basophil; BUN, blood urea nitrogen; CHOL, cholesterol; CRP, C-reactive protein; GGT, γ-glutamyl transferase; GLB, globulin; HCT, haematocrit; LYM, lymphocyte; MONO, monocyte; NEU, neutrophil; PHOS, phosphate; RBC, red blood cell; TP, total protein; WBC, white blood cell..
During hospitalization, immunosuppressants were discontinued, and a combination of two broad-spectrum antibacterial drugs (cefotaxime 30 mg/kg, intravenous [IV], q8h [Pharmgen cefotaxime sodium inj. 1 g, Pharmgen Science, Seoul, Korea] and enrofloxacin 10 mg/kg, IV, q24h [Baytril 50 inj., Yuhan]) was administered. Additionally, the dog received fluid (Plasma Solution-A Inj., HK inno.N Corp., Cheongju, Korea; bolus or continuous rate infusion [CRI]) for hypotension, analgesic treatment (remifentanil 6 μg/kg/hr, lidocaine 3 mg/kg/hr, and ketamine 0.6 mg/kg/hr, CRI), and gastrointestinal medications (esomeprazole 1 mg/kg, IV, q24h [Nexium inj., AstraZeneca, Cambridge, UK] and metoclopramide hydrochloride 0.3 mg/kg, subcutaneous, q12h [Meckool inj., Jeil jeyak, Daegu, Korea]). However, CRP and neutropenia did not stabilize after treatment with these broad-spectrum antibacterial drugs for 2 days (Fig. 4). Therefore, we decided to change the antibacterial drugs, and on day 2, the dog received meropenem (12 mg/kg, IV, q8h [Meropen inj. 0.5 g, Yuhan]) and metronidazole (7.5 mg/kg, IV, q 12h [Trizele inj., JW Pharmaceutical, Gyeonggi, Korea]) for antibacterial treatment. Subsequently, the CRP levels, neutropenia, and injuries markedly improved (Fig. 4). The dog was discharged from the hospital on day 5. On the day of discharge, meropenem and metronidazole for antibacterial treatment, and oxycodone (0.3 mg/kg, PO, q 12h [Ocodone Tab. 5 mg, Hana Pharm, Seoul, Korea]) for analgesia were prescribed . The dog was rechecked on day 21. The CRP level was within the normal reference range, and the clinical signs were completely resolved. However, pemphigus foliaceus relapsed in the dog, and the dog is currently undergoing re-administration of immunosuppressive medications (prednisolone 1 mg/kg, PO, SID and cyclosporine 8 mg/kg, PO, SID).
Millions of animal injuries occur annually (Lauer et al, 1982; Weiss et al, 1998). Among these, 90% involve injuries caused by dogs and cats, and 3∼18% of dog bites result in infections (Talan et al, 1999). Aerobic bacteria commonly isolated from dog bites include
Several studies on the autopsies of patients who died from sepsis revealed significantly suppressed cytokine production in splenocytes (Meakins et al, 1977; Hotchkiss and Karl, 2003). Given this immunosuppressive state in patients with sepsis, there is a current argument to focus not only on appropriate antibiotic therapy and supportive care, but also on enhancing the host’s immunity (Meisel et al, 2009; Hall et al, 2011). Therefore, immunosuppressive therapy the dog was receiving for pemphigus was discontinued.
When there is a recurrence or persistent hypotension due to septic shock, the delay in initiating effective antibiotic treatment significantly increases the risk of death (Kumar et al, 2006a; Kumar et al, 2006b). According to a study by Kumar et al., if effective antibiotic therapy begins within one hour of confirming hypotension, the survival rate markedly improves (Kumar et al, 2006a). However, for each subsequent delay, the average survival rate decreases by 7.6% (Kumar et al, 2006a). This emphasizes the critical importance of early and effective antibiotic interventions (Garnacho-Montero et al, 2003; Larché et al, 2003). Based on this evidence, in this patient, the combination of cefotaxime and enrofloxacin did not improve persistent hypotension and worsening neutropenia. Therefore, treatment was changed to a combination of meropenem and metronidazole (Roberts et al, 2009). Subsequently, the CRP levels, neutropenia, and injury significantly improved.
To the best of our knowledge, this is the first case report of successful management of dog bite-induced sepsis in a dog undergoing long-term immunosuppressive therapy.
This study was supported by the National Research Foundation (NRF) of Korea grant funded by the Korea government (MSIT) (RS-2023-00252033).
The dog described in this report was a client-owned patient presented for care at the veterinary medical teaching hospital of Jeju National University. Informed owner consent was received for any possible research use of all diagnostic samples acquired from the dog.
No potential conflict of interest relevant to this article was reported.
Table 1 . Complete blood count (CBC) and serum chemistry results at initial visit.
CBC | ||
---|---|---|
RBC | 8.86 | 5.65∼8.87 (1012/L) |
HCT | 46 | 37.3∼61.7 (%) |
WBC | 5.87 | 5.05∼16.76 (109/L) |
WBC-NEU † | 2.36 | 2.95∼11.64 (103/µL) |
WBC-LYM † | 1.49 | 1.05∼5.1 (103/µL) |
WBC-MONO† | 2 | 0.16∼1.12 (103/µL) |
WBC-EOS† | 0.02 | 0.06∼1.23 (103/µL) |
WBC-BASO† | 0 | 0∼0.1 (103/µL) |
Platelet | 229 | 148∼484 (109/L) |
Serum chemistry | ||
Glucose | 127 | 74∼143 (mg/dL) |
PHOS | 5.8 | 2.5∼6.8 (mg/dL) |
Calcium | 9.1 | 7.9∼12 (mg/dL) |
TP | 7.3 | 5.2∼ 8.2 (g/dL) |
ALB | 3.1 | 2.3∼ 4 (g/dL) |
GLB | 4.2 | 2.5∼4.5 (g/dL) |
ALT | 167 | 10∼125 (U/L) |
AST | 59 | 0∼50 (U/L) |
ALKP | 2,970 | 23∼212 (U/L) |
GGT | 223 | 0∼11 (U/L) |
Bilirubin-Total | 0.6 | 0∼0.9 (mg/dL) |
CHOL | 261 | 110∼320 (mg/dL) |
Creatinine | 0.6 | 0.5∼1.8 (mg/dL) |
BUN | 6 | 7∼27 (mg/dL) |
CRP | 7.8 | 0.1∼1 (mg/dL) |
ALB, albumin; ALKP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; BASO, basophil; BUN, blood urea nitrogen; CHOL, cholesterol; CRP, C-reactive protein; GGT, γ-glutamyl transferase; GLB, globulin; HCT, haematocrit; LYM, lymphocyte; MONO, monocyte; NEU, neutrophil; PHOS, phosphate; RBC, red blood cell; TP, total protein; WBC, white blood cell..
Shin-Ho Lee, Sujin Kim, Jae-Hyeon Cho
Korean J. Vet. Serv. 2024; 47(3): 185-191 https://doi.org/10.7853/kjvs.2024.47.3.185Unghui Kim, Woo-Jin Song
Korean J. Vet. Serv. 2024; 47(2): 101-105 https://doi.org/10.7853/kjvs.2024.47.2.101Ujin Kim, Woo-Jin Song
Korean J. Vet. Serv. 2024; 47(2): 95-100 https://doi.org/10.7853/kjvs.2024.47.2.95